Mereo BioPharma Group PLC at JPMorgan Healthcare Conference Transcript
All right, everybody. Let's get started. Welcome to the 44th Annual JPMorgan Healthcare Conference. My name is Priyanka Grover, and I'm part of the JPMorgan biotech team. Today, our next presenting company is Mereo and presenting on half of the company as CEO, Denis Scotti.
Denise?
Thank you, Frank, and thank you to JPMorgan for inviting me to speak here today and to host us. So just want to move quickly through the disclaimer and the forward-looking statements. And on to Mereo. So Mereo is a rare disease company. And the 2 young gentlemen that you see here on photograph are Martin and Frei.
And they both have osteogenesis imperfecta or OI. And Martin, who you can see smiling away actually has Type 3 OI, and he's in a wheelchair. And they both came to talk to us about the impact of OI on their lives. They're both students at university and Martin studying to be a medical student.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
